MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

NeoGenomics Inc

Fermé

9.16 1.78

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.97

Max

9.45

Chiffres clés

By Trading Economics

Revenu

-19M

-45M

Ventes

13M

181M

Marge bénéficiaire

-24.867

Employés

2,200

EBITDA

-41M

-48M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+18.16% upside

Dividendes

By Dow Jones

Prochains Résultats

28 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

344M

1.2B

Ouverture précédente

7.38

Clôture précédente

9.16

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

NeoGenomics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 sept. 2025, 14:35 UTC

Principaux Mouvements du Marché

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

7 oct. 2025, 15:15 UTC

Market Talk

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

7 oct. 2025, 12:33 UTC

Acquisitions, Fusions, Rachats

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

7 oct. 2025, 12:32 UTC

Acquisitions, Fusions, Rachats

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

7 oct. 2025, 11:53 UTC

Market Talk

Central Banks Could Add Bitcoin to Reserves -- Market Talk

7 oct. 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 oct. 2025, 07:00 UTC

Market Talk

Bitcoin Eases After Hitting Fresh Record High -- Market Talk

6 oct. 2025, 10:14 UTC

Market Talk

Bitcoin Could Extend Gains on U.S. Government Shutdown -- Market Talk

6 oct. 2025, 07:18 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6 oct. 2025, 07:18 UTC

Market Talk

Bitcoin Stays Stronger After Hitting Record High -- Market Talk

3 oct. 2025, 13:10 UTC

Market Talk

Bitcoin Looks Ripe For Fresh Record High -- Market Talk

3 oct. 2025, 07:20 UTC

Market Talk

Bitcoin Pulls Back as Government Shutdown Delays Key Data -- Market Talk

2 oct. 2025, 13:17 UTC

Acquisitions, Fusions, Rachats

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2 oct. 2025, 13:16 UTC

Acquisitions, Fusions, Rachats

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2 oct. 2025, 13:16 UTC

Acquisitions, Fusions, Rachats

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2 oct. 2025, 13:15 UTC

Acquisitions, Fusions, Rachats

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2 oct. 2025, 07:05 UTC

Market Talk

Global Equities Roundup: Market Talk

2 oct. 2025, 07:05 UTC

Market Talk

Bitcoin Rises Following Wall Street Rally -- Market Talk

1 oct. 2025, 23:12 UTC

Acquisitions, Fusions, Rachats

Avalanche Treasury CEO is Bart Smith

1 oct. 2025, 23:11 UTC

Acquisitions, Fusions, Rachats

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1 oct. 2025, 23:07 UTC

Acquisitions, Fusions, Rachats

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1 oct. 2025, 23:06 UTC

Acquisitions, Fusions, Rachats

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1 oct. 2025, 23:04 UTC

Acquisitions, Fusions, Rachats

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1 oct. 2025, 14:01 UTC

Market Talk

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

1 oct. 2025, 07:27 UTC

Market Talk

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

30 sept. 2025, 14:20 UTC

Principaux Mouvements du Marché

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

30 sept. 2025, 06:51 UTC

Market Talk

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

29 sept. 2025, 13:48 UTC

Market Talk

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

29 sept. 2025, 07:40 UTC

Market Talk

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

26 sept. 2025, 07:29 UTC

Market Talk

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

Comparaison

Variation de prix

NeoGenomics Inc prévision

Objectif de Prix

By TipRanks

18.16% hausse

Prévisions sur 12 Mois

Moyen 10.67 USD  18.16%

Haut 14 USD

Bas 8 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

11 ratings

5

Achat

6

Maintien

0

Vente

Score Technique

By Trading Central

7.7 / 10.27Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat